All Stories

  1. Preparation and Optimization of MiR-375 Nano-Vector Using Two Novel Chitosan-Coated Nano-Structured Lipid Carriers as Gene Therapy for Hepatocellular Carcinoma
  2. Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment
  3. Derivation of “Egyptian varices prediction (EVP) index”: A novel noninvasive index for diagnosing esophageal varices in HCV Patients
  4. Impact of type 2 diabetes mellitus on the immunoregulatory characteristics of adipose tissue-derived mesenchymal stem cells
  5. In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine
  6. Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies
  7. The oral microbiome of treated and untreated chronic HCV infection: A preliminary study
  8. Identifying potential novel insights for COVID-19 pathogenesis and therapeutics using an integrated bioinformatics analysis of host transcriptome
  9. Systematic auditing is essential to debiasing machine learning in biology
  10. Complete genome sequence and bioinformatics analysis of nine Egyptian females with clinical information from different geographic regions in Egypt
  11. Clinical Implications of S100A12 and Resolvin D1 Serum Levels, and Related Genes in Children with Familial Mediterranean Fever
  12. Machine Learning Prediction Models for Diagnosing Hepatocellular Carcinoma with HCV-related Chronic Liver Disease
  13. Immunomodulatory and Antioxidative potentials of adipose-derived Mesenchymal stem cells isolated from breast versus abdominal tissue: a comparative study
  14. Systematic auditing is essential to debiasing machine learning in biology
  15. Expression profiling and analysis of some miRNAs in subcutaneous white adipose tissue during development of obesity
  16. Custommune: a web tool to design personalized and population-targeted vaccine epitopes
  17. Complete genome sequence and analysis of nine Egyptian females with clinical information from different geographic regions in Egypt
  18. Early diagnosis of esophageal varices using Boosted-Naïve Bayes Tree: A multicenter cross-sectional study on chronic hepatitis C patients
  19. Effect of Tumor Suppressor MiR-34a Loaded on ZSM-5 Nanozeolite in Hepatocellular Carcinoma: In Vitro and In Vivo Approach
  20. The Promise of miRNA Replacement Therapy for Hepatocellular Carcinoma
  21. Evaluation of computational techniques for predicting non-synonymous single nucleotide variants pathogenicity
  22. Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
  23. Co-regulatory Network of Oncosuppressor miRNAs and Transcription Factors for Pathology of Human Hepatic Cancer Stem Cells (HCSC)
  24. A review study: Computational techniques for expecting the impact of non-synonymous single nucleotide variants in human diseases
  25. Performance of machine learning approaches on prediction of esophageal varices for Egyptian chronic hepatitis C patients
  26. MicroRNA-150 down Regulation in Acute Myeloid Leukaemia Patients and Its Prognostic Implication
  27. Whole genome sequencing and bioinformatics analysis of two Egyptian genomes
  28. Altered expression of WFS1 and NOTCH2 genes associated with diabetic nephropathy in T2DM patients
  29. Down-regulation of circulating microRNA let-7a in Egyptian smokers
  30. Deep feature selection for Identification of Essential Proteins of Learning and Memory in Mouse Model of Down Syndrome
  31. Comparison of Machine Learning Approaches for Prediction of Advanced Liver Fibrosis in Chronic Hepatitis C Patients
  32. Bioinformatics functional analysis of let-7a, miR-34a, and miR-199a/b reveals novel insights into immune system pathways and cancer hallmarks for hepatocellular carcinoma
  33. MicroTarget: MicroRNA target gene prediction approach with application to breast cancer
  34. In silico identification of potential key regulatory factors in smoking-induced lung cancer
  35. DETECTING AND ANALYZING COPY NUMBER ALTERNATIONS IN ARRAY-BASED CGH DATA
  36. Computational Identification of Tissue-Specific Splicing Regulatory Elements in Human Genes from RNA-Seq Data
  37. Features selection for building an early diagnosis machine learning model for Parkinson's disease
  38. In Silico Design and Experimental Validation of siRNAs Targeting Conserved Regions of Multiple Hepatitis C Virus Genotypes
  39. Modified gold nanoparticles for intracellular delivery of anti-liver cancer siRNA
  40. Accurate Prediction of Advanced Liver Fibrosis Using the Decision Tree Learning Algorithm in Chronic Hepatitis C Egyptian Patients
  41. DeNovo: virus-host sequence-based protein–protein interaction prediction
  42. Comparing PCA to information gain as a feature selection method for Influenza-A classification
  43. New Benzimidazoles and Their Antitumor Effects with Aurora A Kinase and KSP Inhibitory Activities
  44. Correction: MysiRNA-Designer: A Workflow for Efficient siRNA Design
  45. Hsa-miR-195 targets PCMT1 in hepatocellular carcinoma that increases tumor life span
  46. Genetic variability of the core protein in hepatitis C virus genotype 4 in Saudi Arabian patients and its implication on pegylated interferon and ribavirin therapy
  47. Human microRNAs targeting hepatitis C virus
  48. Accurate classification and hemagglutinin amino acid signatures for influenza A virus host-origin association and subtyping
  49. Ensemble-based classification approach for micro-RNA mining applied on diverse metagenomic sequences
  50. An Integrative Meta-analysis of MicroRNAs in Hepatocellular Carcinoma
  51. Hepatitis C virus genotype 1: How genetic variability of the core protein affects the response to pegylated‐interferon and ribavirin therapy
  52. 283 PREDICTION OF miRNA TARGET GENES INVOLVED IN LIVER CANCER PATHWAYS AND ITS VALIDATION
  53. Synthesis, pharmacological activity evaluation and molecular modeling of new polynuclear heterocyclic compounds containing benzimidazole derivatives
  54. Multiple virtual screening approaches for finding new Hepatitis c virus RNA-dependent RNA polymerase inhibitors: Structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitors
  55. Rational Drug Design for Identifying Novel Multi-target Inhibitors for Hepatocellular Carcinoma
  56. Structure-based predictive model for some benzimidazole inhibitors of hepatitis C virus NS5B polymerase
  57. Accurate Prediction of Response to Interferon-based Therapy in Egyptian Patients with Chronic Hepatitis C Using Machine-learning Approaches
  58. MysiRNA: Improving siRNA efficacy prediction using a machine-learning model combining multi-tools and whole stacking energy (ΔG)
  59. INFLUENZA A SUBTYPING AND HOST ORIGIN CLASSIFICATION USING PROFILE HIDDEN MARKOV MODELS
  60. Recurrent Neural Networks and Soft Computing
  61. In-silico Approaches for RNAi Post-Transcriptional Gene Regulation: Optimizing siRNA Design and Selection
  62. MysiRNA-Designer: A Workflow for Efficient siRNA Design
  63. The design of optimal therapeutic small interfering RNA molecules targeting diverse strains of influenza A virus
  64. Generation, characterization, and docking studies of DNA‐hydrolyzing recombinant Fab antibodies
  65. ChemInform Abstract: Part 1. Synthesis, Cancer Chemopreventive Activity and Molecular Docking Study of Novel Quinoxaline Derivatives.
  66. Genomic signatures and associative classification of the Hemagglutinin protein for Human versus Avian versus Swine influenza A viruses
  67. Classification of human vs. non-human, and subtyping of human influenza viral strains using Profile Hidden Markov Models
  68. Identification of novel conserved functional motifs across most Influenza A viral strains
  69. Part I: Synthesis, cancer chemopreventive activity and molecular docking study of novel quinoxaline derivatives
  70. Prediction of prognostic biomarkers for Interferon-based therapy to Hepatitis C Virus patients: a metaanalysis of the NS5A protein in subtypes 1a, 1b, and 3a
  71. An Integrated Methodology for Mining Promiscuous Proteins: A Case Study of an Integrative Bioinformatics Approach for Hepatitis C Virus Non-structural 5a Protein
  72. Natural Genetic Engineering of Hepatitis C Virus NS5A for Immune System Counterattack
  73. Correlating novel variable and conserved motifs in the Hemagglutinin protein with significant biological functions
  74. Phylogenetic analysis and comparison between cow and buffalo (including Egyptian buffaloes) mitochondrial displacement-loop regions